Salivary IgA in response to periodontal treatment

European Journal of Oral Sciences

Volumn 111, Issue 3, 2003, Pages 203-208

  Hägewald, Stefan J ^a   Fishel, Daniel L W ^b   Christan, Claudia E B ^a   Bernimoulin, Jean Pierre ^a   Kage, Andreas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Aggressive periodontitis; Enzyme linked immunosorbent assay (ELISA); Mucosal immunology; Porphyromonas gingivalis; Salivary IgA

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; METRONIDAZOLE; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; SALIVA PROTEIN; SECRETORY IMMUNOGLOBULIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PATIENT MONITORING; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROGNOSIS; SALIVA LEVEL; SALIVARY GLAND; STATISTICAL ANALYSIS; ADOLESCENT; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PREVENTIVE DENTISTRY; SALIVA; STATISTICAL MODEL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; DENTAL SCALING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; LOGISTIC MODELS; MALE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SALIVA; SALIVARY PROTEINS;

EID: 18344400380     PISSN: 09098836     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0722.2003.00040.x     Document Type: Article

References (47)

1. ARMITAGE GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1-6.
2. TONETTI MS, MOMBELLI A. Early-onset periodontitis. Ann Periodontol 1999; 4: 39-53.
3. RANNEY RR. Classification of periodontal diseases. Periodontology 2000; 2: 13-25.
4. GORDON J, WALKER C, LAMSTER I, WEST T, SOCRANSKY S, SEIGER M, FASCIANO R. Efficacy of clindamycin hydrochloride in refractory periodontitis: 12-month results. J Periodontol 1985; 56: 75-80.
5. REDDY MS, PALCANIS KG, BARNETT ML, HAIGH S, CHARLES CH, JEFFCOAT MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993; 20: 635-640.
6. KAMMA JJ, NAKOU M, MANTI FA. Predominant microflora of severe, moderate and minimal periodontal lesions in young adults with rapidly progressive periodontitis. J Periodontal Res 1995; 30: 66-72.
7. GUNSOLLEY JC, BURMEISTER JA, TEW JG, BEST AM, RANNEY RR. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol 1987; 58: 314-320.
8. CHEN HA, JOHNSON BD, SIMS TJ, DARVEAU RP, MONCLA BJ, WHITNEY CW, ENGEL D, PAGE RC. Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol 1991; 62: 781-791.
9. MOONEY J, KINANE DF. Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis. Oral Microbiol Immunol 1994; 9: 321-326.
10. CHALLACOMBE SJ, SWEET SP. Oral mucosal immunity and HIV infection: current status. Oral Dis 2002; 8: 55-62.
11. MYINT MM, STEINSVOLL S, ODDEN K, DOBLOUG J, SCHENCK K. Salivary IgA responses to bacteria in dental plaque as related to periodontal and HIV infection status. Eur J Oral Sci 1997; 105: 562-570.
12. HAGEWALD S, BERNIMOULIN JP, KOTTGEN E, KAGE A. Total IgA and Porphyromonas gingivalis-renctive IgA in the saliva of patients with generalised early-onset periodontitis. Eur J Oral Sci 2000; 108: 147-153.
13. MARCOTTE H, LAVOIE MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 1998; 62: 71-109.
14. OGRA PLMJ, LAMM ME, STROBER W, BIENENSTOCK J, MCGHEE JR, eds. Mucosal immunology, 2nd edn. San Diego: Academic Press, 1998.
15. CUNNINGHAM-RUNDLES C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001; 21: 303-309.
16. SINGH PK, PARSEK MR, GREENBERG EP, WELSH MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 552-555.
17. MACPHERSON AJ, GATTO D, SAINSBURY E, HARRIMAN GR, HENGARTNER H, ZINKERNAGEL RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288: 2222-2226.
18. MACPHERSON AJ, LAMARRE A, MCCOY K, HARRIMAN GR, ODERMATT B, DOUGAN G, HENGARTNER H, ZINKERNAGEL RM. IgA production without mu or delta chain expression in developing B cells. Nat Immunol 2001; 2: 625-631.
19. WANG HYEJ, SMITH DJ, TAUBMAN MA. Salivary IgA antibody in periodontal diseases: a case-control study. Immunol Infect Dis 1992; 2: 87-96.
20. HENSKENS YM, VAN DER WEIJDEN FA, VAN DEN KEIJBUS PA, VEERMAN EC, TIMMERMAN MF, VAN DER VELDEN U, AMERONGEN AV. Effect of periodontal treatment on the protein composition of whole and parotid saliva. J Periodontol 1996; 67: 205-212.
21. CELENLIGIL H, EBERSOLE JL. Characteristics and responses of EBV immortalized B cells from periodontal disease patients. Oral Dis 1997; 3: 262-271.
22. KATZ J, MICHALEK SM. Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis. Oral Microbiol Immunol 1998; 13: 73-80.
23. BOS NA, JIANG HQ, CEBRA JJ. T cell control of the gut IgA response against commensal bacteria. Gut 2001; 48: 762-764.
24. BOSCH JA, DE GEUS EJ, KELDER A, VEERMAN EC, HOOGSTRATEN J, AMERONGEN AV. Differential effects of active versus passive coping on secretory immunity. Psychophysiology 2001; 38: 836-846.
25. TALHAM GL, JIANG HQ, BOS NA, CEBRA JJ. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999; 67: 1992-2000.
26. OGRA PL, FADEN H, WELLIVER RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001; 14: 430-445.
27. DE NARDIN E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol 2001; 6: 30-40.
28. CHOI J, BORRELLO MA, SMITH E, CUTLER CW, SOJAR H, ZAUDERER M. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis. Oral Microbiol Immunol 2001; 16: 338-344.
29. PODMORE M, EBERSOLE JL, KINANE DF. Immunodominant antigens in periodontal disease: a real or illusive concept? Crit Rev Oral Biol Med 2001; 12: 179-185.
30. SANDHOLM L, GRONBLAD E. Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings. J Periodontol 1984; 55: 9-12.
31. NIEMINEN A, KARI K, SAXEN L. Specific antibodies against Actinobacillus actinomycetemcomitans in serum and saliva of patients with advanced periodontitis. Scand J Dent Res 1993; 101: 196-201.
32. HENSKENS YM, VAN DEN KEIJBUS PA, VEERMAN EC, VAN DER WEIJDEN GA, TIMMERMAN MF, SNOEK CM, VAN DER VELDEN U, NIEUW AMERONGEN AV. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J Periodontal Res 1996; 31: 57-65.
33. LIE MA, MYINT MM, SCHENCK K, TIMMERMAN MF, VAN DER VELDEN U, VAN DER WEIJDEN GA, LOOS BG. Parotid salivary S-IgA antibodies during experimental gingivitis in smokers and non-smokers. J Periodontal Res 2002; 37: 86-92.
34. LEISHMAN AJ, GARSIDE P, MOWAT AM. Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form. Cell Immunol 2000; 202: 71-78.
35. FUJIHASHI K, KATO H, VAN GINKEL FW, KOGA T, BOYAKA PN, JACKSON RJ, KATO R, HAGIWARA Y, ETANI Y, GOMA I, KIYONO H, MCGHEE JR. A revisit of mucosal IgA immunity and oral tolerance. Acta Odontol Scand 2001; 59: 301-308.
36. SMITH KM, MCASKILL F, GARSIDE P. Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J Immunol 2002; 168: 4318-4325.
37. HUSBY S, MESTECKY J, MOLDOVEANU Z, HOLLAND S, ELSON CO. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J Immunol 1994; 152: 4663-4670.
38. DE NARDIN AM, SOJAR HT, GROSSI SG, CHRISTERSSON LA, GENCO RJ. Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis. Infect Immun 1991; 59: 4363-4370.
39. SMITH DJ, KING WF, AKITA H, TAUBMAN MA. Association of salivary immunoglobulin A antibody and initial mutans streptococcal infection. Oral Microbiol Immunol 1998; 13: 278-285.
40. CUGINI MA, HAFFAJEE AD, SMITH C, KENT RL JR, SOCRANSKY SS. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 2000; 27: 30-36.
41. FERES M, HAFFAJEE AD, ALLARD K, SOM S, SOCRANSKY SS. Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. J Clin Periodontol 2001; 28: 597-609.
42. BLANCHARD SB, COX SE, EBERSOLE JL. Salivary IgA responses to Porphyromonas gingivalis in the cynomolgus monkey. 1. Total IgA and IgA antibody levels to P. gingivalis. Oral Microbiol Immunol 1991; 6: 341-349.
43. KINANE DF, LAPPIN DF, KOULOURI O, BUCKLEY A. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin Exp Immunol 1999; 115: 534-541.
44. GUO S, TAKAHASHI K, KOKEGUCHI S, TAKASHIBA S, KINANE DF, MURAYAMA Y. Antibody responses against Porphyromonas gingivalis infection in patients with early-onset periodontitis. J Clin Periodontol 2000; 27: 769-777.
45. PERSSON GR, ENGEL D, WHITNEY C, DARVEAU R, WEINBERG A, BRUNSVOLD M, PAGE RC. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun 1994; 62: 1026-1031.
46. BUTLER JE, SPRADLING JE, PETERMAN JH, JOSHI KS, SATAM M, CHALLACOMBE SJ. Humoral immunity in root caries in an elderly population. 1. Oral Microbiol Immunol 1990; 5: 98-107.
47. COOGAN MM, SWEET SP, CHALLACOMBE SJ. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 1994; 62: 892-896.